Phase II study of antineoplastons A10 and AS2-1 in adult patients with anaplastic astrocytoma

Trial Profile

Phase II study of antineoplastons A10 and AS2-1 in adult patients with anaplastic astrocytoma

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
  • Indications Anaplastic astrocytoma
  • Focus Therapeutic Use
  • Sponsors Burzynski Research Institute
  • Most Recent Events

    • 25 Oct 2016 Status changed from recruiting to completed.
    • 18 Jun 2015 Results in recurrent anaplastic astrocytoma patients published in Cancer and Clinical Oncology, according to a Burzynski Research Institute media release.
    • 18 Jun 2015 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top